Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin

PURPOSE: We examined the outcome of patients with newly diagnosed acute promyelocytic leukemia (APL) treated with all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) with or without gemtuzumab ozogamicin (GO) but without traditional cytotoxic chemotherapy. PATIENTS AND METHODS: From February 2...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Ravandi, Farhad, Estey, Eli, Jones, Dan, Faderl, Stefan, O'Brien, Susan, Fiorentino, Jackie, Pierce, Sherry, Blamble, Deborah, Estrov, Zeev, Wierda, William, Ferrajoli, Alessandra, Verstovsek, Srdan, Garcia-Manero, Guillermo, Cortes, Jorge, Kantarjian, Hagop
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2009
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4881307/
https://ncbi.nlm.nih.gov/pubmed/19075265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.6130
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares